Tempus AI fell 10% as a broad market selloff pulled shares lower.
Why Tempus AI Stock Is Falling Today
Today, a broad market selloff pulled Tempus AI Inc. down 10% to $53.78 during regular trading hours. Shares tied to artificial intelligence, software that finds patterns in data, also faced selling across the market.
Tempus AI Exposure to Growth Selling
The Nasdaq Composite, a measure of prices for stocks listed on the Nasdaq exchange, also dropped sharply as AI shares sold off. That decline provides context for Tempus’s move beyond its own business news. Tempus sells AI-based services, giving it exposure to shifts in interest in that technology.
Tempus AI and Future Earnings
Investors demanding a greater reward for risk pay less today for earnings expected later. Tempus’s current losses add context to its steeper decline, but do not establish how much of the gap they explain. The selling does not establish weaker testing demand or lost contracts.
Quick Financial Overview
Tempus has real sales but remains unprofitable, with $9.81B in stock-market value making it a mid-cap, meaning a medium-sized public company. It held $637.4M in cash, cash equivalents, and short-term investments as of September 30, 2026. That includes money on hand and investments that can be turned into cash.
What Tempus AI Inc. Does
Tempus sells tests that examine biological material for markers that can guide treatment. It combines patient information with artificial intelligence to help doctors choose care and drugmakers conduct research.
Tempus AI Revenue and Earnings
Quarterly revenue was $411.5M, alongside a net loss of $14.9M, meaning expenses exceeded revenue. Its day-to-day business activities generated cash during the quarter, so the accounting loss was not the same as cash leaving the business.
Tempus AI Securities Sale Document
Tempus filed a prospectus last month, a document describing investments such as shares or bonds that may be sold. Its existence alone does not establish that new shares were issued or that existing owners’ percentage stakes shrank.
Tempus AI Stock Retreats From Its Advance
Tempus remains up 16% from the $45 level six months ago. The retreat from the $70 level over the latest week is eroding that advance. For Tempus, the last daily move this large was nine sessions ago.
Trading Perspective
The stock is below the $60 level, making that a recovery reference rather than a level currently stopping declines. Farther above sits the $90 level, its annual-high reference. Recovering the nearer level would not prove the retreat has ended.
Tempus AI AstraZeneca Agreement Extension
The decline comes after drugmaker AstraZeneca extended its services agreement with Tempus. That preserves a longer customer relationship, although the extension alone does not show when revenue will be recorded.
Conclusion
The next consumer spending inflation report offers a macro checkpoint for Tempus. Softer inflation could support expectations for lower interest rates, making future earnings worth more today. Hotter inflation could keep pressure on its growth-based value, while an expected reading would offer less reason to reassess it.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:







Leave a reply